Company Profile

Implant Sciences Corporation
Profile last edited on: 3/26/2018      CAGE: 0ATR5      UEI: YN41K9NAXA28

Business Identifier: Sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets.
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

500 Research Drive Unit 3
Wilmington, MA 01887
   (978) 752-1700
Location: Single
Congr. District: 06
County: Middlesex

Public Profile

Involved in SBIR from soon after the firm was established, Implant Sciences Corporation (Implant Sciences) publicly traded from mid-1999 until 2017. In the early days the firm earned a good reputation - developing leading technologies in several markets, including medical products and semiconductor manufacturing. A number of deals and collaboration organized around the firm's work in the radiation therapy implants and thin film device coating space. In 2008 the Company restructured to a single business focus - a pure play in global Security, Safety, and Defense (SS&D) markets. The Company’s patented technology, used in its flagship products, the QS-H150 handheld explosives trace detector and the QS-B220 desktop explosives and drugs trace detector, is in use throughout the world.developing, manufacturing and selling sensors and systems for the security, safety and defense (SS&D) industries. Its technologies are used worldwide in security and inspection applications. Implant Sciences has developed technologies used in explosives trace detection (ETD), and and narcotics trace detection (NTD) applications and market and sell handheld ETD and benchtop ETD and NTD systems that use its technologies. The systems are used by private companies and Government agencies to screen baggage, cargo, vehicles, other objects and people for the detection of trace amounts of explosives. Implant Sciences have developed explosives detection systems designed for use in aviation and transportation security, high threat facilities and infrastructure, military installations, customs and border protection, and mail and cargo screening. In January 2017, it was announced that L3 Technologies - already having by far the the largest number of SBIR acquisitions - had completed acquisition of Implant Sciences' Explosives Trace Detection (ETD) assets.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2008 2 DHS $850,000
Project Title: Handheld Trace Explosives Sampler
2006 2 NIH $863,557
Project Title: Novel Brachytherapy Plaque for Dural Irradiation
2004 2 NIH $814,701
Project Title: Novel 125I Uniformly Distributed Ophthalmic Plaques
2004 2 Army $849,702
Project Title: Fast Response Chemical Sensor for Landmine Multi-Detector Device
2004 1 EPA $70,000
Project Title: Ultrasensitive Toxic Chemical Detector

Key People / Management

  Glenn D Bolduc -- President and Chief Executive Officer

  Bill McGann -- CEO

  Anthony J Armini -- Former President

  Clara Bajgar

  Brenda Baron -- Vice President, Manufacturing Operations

  Stephen N Bunker -- Vice President, Chief Scientist, Director

  Roger Deschenes -- CFO

  Darryl Jones -- Vice President, Global Sales and Marketing

  Daniel Jonsen

  Leonid Krasnobaev

  Paul H Maruska

  David C Medich

  John J Munro

  Diane J Ryan -- Vice President, Administration

  Todd Silvestri -- Vice President, Technology

  Phillip Stark

  Phillip C Thomas